Dr. Martens Valuation

Q: What is the Fair Price of DOCSL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

DOCSL (£0.55) is trading below our estimate of [[fair value]] (£0.93)

Is DOCSL undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

6/6

Valuation Score 6/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of DOCSL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: DOCSL (£0.55) is trading below our estimate of fair value (£0.93)

Significantly Below Fair Value: DOCSL is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for DOCSL?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for DOCSL. This is calculated by dividing DOCSL's market cap by their current preferred multiple.
What is DOCSL's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	UK£531.13m

DOCSL key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1x
Enterprise Value/EBITDA	6.3x
PEG Ratio	1.4x

Price to Earnings Ratio vs Peers

How does DOCSL's PE Ratio compare to its peers?

The above table shows the PE ratio for DOCSL vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	19.4x
COA Coats Group	19.9x	17.5%	UK£1.5b
GLE MJ Gleeson	19.8x	16.3%	UK£381.7m
BOOT Henry Boot	28x	25.5%	UK£316.7m
BRBY Burberry Group	10x	-0.03%	UK£2.7b
DOCSL Dr. Martens	7.7x	5.7%	UK£531.1m

Price-To-Earnings vs Peers: DOCSL is good value based on its Price-To-Earnings Ratio (7.7x) compared to the peer average (19.4x).

Price to Earnings Ratio vs Industry

How does DOCSL's PE Ratio compare vs other companies in the European Luxury Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	9.9%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	9.9%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: DOCSL is good value based on its Price-To-Earnings Ratio (7.7x) compared to the European Luxury industry average (14.8x).

Price to Earnings Ratio vs Fair Ratio

What is DOCSL's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

DOCSL PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	7.7x
Fair PE Ratio	13.5x

Price-To-Earnings vs Fair Ratio: DOCSL is good value based on its Price-To-Earnings Ratio (7.7x) compared to the estimated Fair Price-To-Earnings Ratio (13.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst DOCSL forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	UK£0.55	UK£0.76 +38.7%	12.9%	UK£0.95	UK£0.60	n/a	8
Oct ’25	UK£0.56	UK£0.78 +39.6%	10.5%	UK£0.95	UK£0.70	n/a	8
Sep ’25	UK£0.72	UK£0.78 +7.9%	10.5%	UK£0.95	UK£0.70	n/a	8
Aug ’25	UK£0.69	UK£0.78 +11.6%	10.7%	UK£0.95	UK£0.70	n/a	8
Jul ’25	UK£0.74	UK£0.77 +4.4%	10.7%	UK£0.95	UK£0.70	n/a	8
Jun ’25	UK£0.87	UK£0.75 -13.5%	11.6%	UK£0.95	UK£0.65	n/a	8
May ’25	UK£0.78	UK£0.77 -1.5%	18.6%	UK£1.10	UK£0.65	n/a	8
Apr ’25	UK£0.88	UK£0.96 +8.4%	10.9%	UK£1.10	UK£0.85	n/a	9
Mar ’25	UK£0.97	UK£0.98 +1.5%	9.4%	UK£1.10	UK£0.85	n/a	9
Feb ’25	UK£0.85	UK£0.98 +15.5%	9.4%	UK£1.10	UK£0.85	n/a	9
Jan ’25	UK£0.89	UK£1.22 +37.7%	16.8%	UK£1.60	UK£1.00	n/a	9
Dec ’24	UK£0.96	UK£1.35 +40.4%	12.3%	UK£1.60	UK£1.10	n/a	9
Nov ’24	UK£1.18	UK£1.59 +34.7%	14.2%	UK£2.15	UK£1.40	n/a	9
Oct ’24	UK£1.42	UK£1.59 +11.7%	14.2%	UK£2.15	UK£1.40	UK£0.56	9
Sep ’24	UK£1.57	UK£1.59 +0.9%	14.2%	UK£2.15	UK£1.40	UK£0.72	9
Aug ’24	UK£1.45	UK£1.59 +9.5%	14.2%	UK£2.15	UK£1.40	UK£0.69	9
Jul ’24	UK£1.23	UK£1.64 +32.8%	16.9%	UK£2.15	UK£1.40	UK£0.74	9
Jun ’24	UK£1.38	UK£1.92 +39.5%	15.4%	UK£2.50	UK£1.52	UK£0.87	9
May ’24	UK£1.67	UK£2.04 +21.8%	19.2%	UK£2.72	UK£1.52	UK£0.78	9
Apr ’24	UK£1.42	UK£2.08 +46.7%	24.6%	UK£3.00	UK£1.40	UK£0.88	8
Mar ’24	UK£1.55	UK£2.11 +36.0%	22.0%	UK£3.00	UK£1.40	UK£0.97	9
Feb ’24	UK£1.59	UK£2.54 +60.1%	30.9%	UK£4.00	UK£1.40	UK£0.85	8
Jan ’24	UK£1.90	UK£3.35 +75.9%	22.4%	UK£5.00	UK£2.50	UK£0.89	8
Dec ’23	UK£2.11	UK£3.52 +66.6%	24.6%	UK£5.00	UK£2.50	UK£0.96	8
Nov ’23	UK£2.50	UK£3.83 +53.3%	20.4%	UK£5.50	UK£2.76	UK£1.18	8
Oct ’23	UK£2.22	UK£3.89 +75.2%	20.1%	UK£5.50	UK£2.76	UK£1.42	8

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.